购物车
  • TargetMol
    您的购物车当前为空

Rg3039

一键复制产品信息
Rating icon 很棒

纯度: 99.58%

货号 T3336Cas号 1005504-62-0

别名 PF-06687859

Rg3039 (PF-06687859) 是一种具有口服活性、能够透过血脑屏障的DcpS 抑制剂,其IC50=0.069 nM。

Rg3039
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

Rg3039

一键复制产品信息
Rating icon 很棒

纯度: 99.58%

货号 T3336 别名 PF-06687859Cas号 1005504-62-0

Rg3039 (PF-06687859) 是一种具有口服活性、能够透过血脑屏障的DcpS 抑制剂,其IC50=0.069 nM。

规格价格库存数量
2 mg
¥ 297
现货
5 mg
¥ 496
现货
10 mg
¥ 792
现货
25 mg
¥ 1,590
现货
50 mg
¥ 2,430
现货
100 mg
¥ 3,580
现货
500 mg
¥ 7,780
现货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
选择批次:
纯度: 99.58%
颜色: 白色
性状: Solid
联系我们 获取更多批次信息

产品介绍


Rg3039 AI Summary
Rg3039 exhibits potent inhibition of human DcpS with an IC50 of 0.069 nM, indicating potential as a therapeutic agent for increasing SMN2 promoter activity. It also shows an IC50 of 4.2 nM for the same enzyme and demonstrates significant brain distribution in the spinal muscular atrophy mouse model, with an AUC of 6762.0 ng.hr.mL-1 and a high brain to plasma ratio of 16.0. The compound's pharmacokinetic profile includes high intrinsic clearance in human liver microsomes (> 250.0 mL.min-1.g-1), good passive cell permeability, and a high efflux ratio in MDR1-expressing cells. It has a log D value of 2.8 at pH 7.4 and high kinetic solubility at pH 6.5. Although it shows good stability in human liver microsomes with a stability of 3.0 minutes at 1 uM, it also exhibits moderate cytotoxicity against human HepG2 cells with an IC50 value of 4000.0 nM. In terms of antiviral activity, Rg3039 inhibits SARS-CoV-2 3CL-Pro protease activity by 13.4% at a concentration of 20μM and shows antiviral effects in VERO-6 cells at 10 uM concentration with an inhibition rate of -0.33% after 48 hours of exposure. The compound's efficacy and activity in the spinal muscular atrophy mouse model vary, demonstrating survival rates ranging from 26.0% to 90.0% depending on dosing and administration routes..
Note: Summary generated by AI. Data source: ChEMBL
生物活性
产品描述
Rg3039 (PF-06687859) is a potent DcpS inhibitor. DcpS is a therapeutic target for spinal muscular atrophy. Spinal muscular atrophy (SMA) is caused by deletion or mutation of both copies of the SMN1 gene which produces an essential protein known as SMN. RG3039 improves motor function in SMA mice. RG3039 also showed activity to improve survival, function and motor unit pathologies in two SMA mouse models.
靶点活性
DcpS:0.069 nM.
别名PF-06687859
化学信息
分子量432.35
分子式C21H23Cl2N5O
CAS No.1005504-62-0
SmilesNc1nc(N)c2c(OCC3CCN(Cc4c(Cl)cccc4Cl)CC3)cccc2n1
密度1.375 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度信息
H2O: < 0.1 mg/mL (insoluble)
DMSO: 2.69 mg/mL (6.22 mM), Sonication is recommended.
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.3129 mL11.5647 mL23.1294 mL115.6470 mL
5 mM0.4626 mL2.3129 mL4.6259 mL23.1294 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSOPEG300PEG400Tween 80SBE-β-CD玉米油等, 均可在TargetMol网站点击购买。
1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

Related Tags: buy Rg3039 | purchase Rg3039 | Rg3039 cost | order Rg3039 | Rg3039 chemical structure | Rg3039 formula | Rg3039 molecular weight